Pharmacokinetics Services Market - Global Outlook and Forecast 2023-2027

Report ID: 923675 | Published Date: Oct 2024 | No. of Page: 90 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Pharmacokinetics Services Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pharmacokinetics Services Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pharmacokinetics Services Overall Market Size
    2.1 Global Pharmacokinetics Services Market Size: 2021 VS 2027
    2.2 Global Pharmacokinetics Services Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pharmacokinetics Services Players in Global Market
    3.2 Top Global Pharmacokinetics Services Companies Ranked by Revenue
    3.3 Global Pharmacokinetics Services Revenue by Companies
    3.4 Top 3 and Top 5 Pharmacokinetics Services Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Pharmacokinetics Services Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pharmacokinetics Services Players in Global Market
        3.6.1 List of Global Tier 1 Pharmacokinetics Services Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pharmacokinetics Services Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Pharmacokinetics Services Market Size Markets, 2021 & 2027
        4.1.2 Small Molecules Pharmacokinetics Services
        4.1.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
    4.2 By Type - Global Pharmacokinetics Services Revenue & Forecasts
        4.2.1 By Type - Global Pharmacokinetics Services Revenue, 2016-2021
        4.2.2 By Type - Global Pharmacokinetics Services Revenue, 2022-2027
        4.2.3 By Type - Global Pharmacokinetics Services Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pharmacokinetics Services Market Size, 2021 & 2027
        5.1.2 Small & Medium Enterprise
        5.1.3 Large Enterprise
    5.2 By Application - Global Pharmacokinetics Services Revenue & Forecasts
        5.2.1 By Application - Global Pharmacokinetics Services Revenue, 2016-2021
        5.2.2 By Application - Global Pharmacokinetics Services Revenue, 2022-2027
        5.2.3 By Application - Global Pharmacokinetics Services Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Pharmacokinetics Services Market Size, 2021 & 2027
    6.2 By Region - Global Pharmacokinetics Services Revenue & Forecasts
        6.2.1 By Region - Global Pharmacokinetics Services Revenue, 2016-2021
        6.2.2 By Region - Global Pharmacokinetics Services Revenue, 2022-2027
        6.2.3 By Region - Global Pharmacokinetics Services Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Pharmacokinetics Services Revenue, 2016-2027
        6.3.2 US Pharmacokinetics Services Market Size, 2016-2027
        6.3.3 Canada Pharmacokinetics Services Market Size, 2016-2027
        6.3.4 Mexico Pharmacokinetics Services Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Pharmacokinetics Services Revenue, 2016-2027
        6.4.2 Germany Pharmacokinetics Services Market Size, 2016-2027
        6.4.3 France Pharmacokinetics Services Market Size, 2016-2027
        6.4.4 U.K. Pharmacokinetics Services Market Size, 2016-2027
        6.4.5 Italy Pharmacokinetics Services Market Size, 2016-2027
        6.4.6 Russia Pharmacokinetics Services Market Size, 2016-2027
        6.4.7 Nordic Countries Pharmacokinetics Services Market Size, 2016-2027
        6.4.8 Benelux Pharmacokinetics Services Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Pharmacokinetics Services Revenue, 2016-2027
        6.5.2 China Pharmacokinetics Services Market Size, 2016-2027
        6.5.3 Japan Pharmacokinetics Services Market Size, 2016-2027
        6.5.4 South Korea Pharmacokinetics Services Market Size, 2016-2027
        6.5.5 Southeast Asia Pharmacokinetics Services Market Size, 2016-2027
        6.5.6 India Pharmacokinetics Services Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Pharmacokinetics Services Revenue, 2016-2027
        6.6.2 Brazil Pharmacokinetics Services Market Size, 2016-2027
        6.6.3 Argentina Pharmacokinetics Services Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pharmacokinetics Services Revenue, 2016-2027
        6.7.2 Turkey Pharmacokinetics Services Market Size, 2016-2027
        6.7.3 Israel Pharmacokinetics Services Market Size, 2016-2027
        6.7.4 Saudi Arabia Pharmacokinetics Services Market Size, 2016-2027
        6.7.5 UAE Pharmacokinetics Services Market Size, 2016-2027
7 Players Profiles
    7.1 Evotec AG (Germany)
        7.1.1 Evotec AG (Germany) Corporate Summary
        7.1.2 Evotec AG (Germany) Business Overview
        7.1.3 Evotec AG (Germany) Pharmacokinetics Services Major Product Offerings
        7.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.1.5 Evotec AG (Germany) Key News
    7.2 Pacific BioLabs (US)
        7.2.1 Pacific BioLabs (US) Corporate Summary
        7.2.2 Pacific BioLabs (US) Business Overview
        7.2.3 Pacific BioLabs (US) Pharmacokinetics Services Major Product Offerings
        7.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.2.5 Pacific BioLabs (US) Key News
    7.3 GVK Biosciences Private Limited (India)
        7.3.1 GVK Biosciences Private Limited (India) Corporate Summary
        7.3.2 GVK Biosciences Private Limited (India) Business Overview
        7.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Major Product Offerings
        7.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.3.5 GVK Biosciences Private Limited (India) Key News
    7.4 Shanghai Medicilon Inc. (China)
        7.4.1 Shanghai Medicilon Inc. (China) Corporate Summary
        7.4.2 Shanghai Medicilon Inc. (China) Business Overview
        7.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Major Product Offerings
        7.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.4.5 Shanghai Medicilon Inc. (China) Key News
    7.5 Pharmaceutical Product Development, LLC (US)
        7.5.1 Pharmaceutical Product Development, LLC (US) Corporate Summary
        7.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
        7.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Major Product Offerings
        7.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.5.5 Pharmaceutical Product Development, LLC (US) Key News
    7.6 Charles River Laboratories International, Inc. (US)
        7.6.1 Charles River Laboratories International, Inc. (US) Corporate Summary
        7.6.2 Charles River Laboratories International, Inc. (US) Business Overview
        7.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Major Product Offerings
        7.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.6.5 Charles River Laboratories International, Inc. (US) Key News
    7.7 PAREXEL International Corporation (US)
        7.7.1 PAREXEL International Corporation (US) Corporate Summary
        7.7.2 PAREXEL International Corporation (US) Business Overview
        7.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Major Product Offerings
        7.4.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.7.5 PAREXEL International Corporation (US) Key News
    7.8 Eurofins Scientific, Inc. (Luxembourg)
        7.8.1 Eurofins Scientific, Inc. (Luxembourg) Corporate Summary
        7.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
        7.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Major Product Offerings
        7.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.8.5 Eurofins Scientific, Inc. (Luxembourg) Key News
    7.9 Frontage Labs (US)
        7.9.1 Frontage Labs (US) Corporate Summary
        7.9.2 Frontage Labs (US) Business Overview
        7.9.3 Frontage Labs (US) Pharmacokinetics Services Major Product Offerings
        7.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.9.5 Frontage Labs (US) Key News
    7.10 SGS SA (Switzerland)
        7.10.1 SGS SA (Switzerland) Corporate Summary
        7.10.2 SGS SA (Switzerland) Business Overview
        7.10.3 SGS SA (Switzerland) Pharmacokinetics Services Major Product Offerings
        7.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.10.5 SGS SA (Switzerland) Key News
    7.11 LGC Limited (UK)
        7.11.1 LGC Limited (UK) Corporate Summary
        7.11.2 LGC Limited (UK) Business Overview
        7.11.3 LGC Limited (UK) Pharmacokinetics Services Major Product Offerings
        7.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.11.5 LGC Limited (UK) Key News
    7.12 Creative Bioarray (US)
        7.12.1 Creative Bioarray (US) Corporate Summary
        7.12.2 Creative Bioarray (US) Business Overview
        7.12.3 Creative Bioarray (US) Pharmacokinetics Services Major Product Offerings
        7.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.12.5 Creative Bioarray (US) Key News
    7.13 Certara, L.P. (Germany)
        7.13.1 Certara, L.P. (Germany) Corporate Summary
        7.13.2 Certara, L.P. (Germany) Business Overview
        7.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Major Product Offerings
        7.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue in Global (2016-2021)
        7.13.5 Certara, L.P. (Germany) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
104
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Pharmacokinetics Services Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmacokinetics Services Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmacokinetics Services Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports